RS6031431 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| systolic blood pressure (SBP, maximum, inv-normal transformed) | A | β: 0.027 | 2E-25 | PubMed |
| Systolic blood pressure | G | OR: 0.28 | 6E-17 | PubMed |
| Systolic blood pressure (MTAG) | G | β: 0.014 | 1E-16 | PubMed |
| Hypertension | G | β: 0.039 | 4E-16 | PubMed |
| potassium (mean, inv-norm transformed) | A | β: 0.02 | 2E-15 | PubMed |
| Atrial fibrillation | A | β: 0.029 | 3E-15 | PubMed |
| systolic blood pressure (SBP, mean, inv-normal transformed) | A | β: 0.034 | 5E-15 | PubMed |
| Medication use (calcium channel blockers) | G | β: 0.045 | 6E-14 | PubMed |
| potassium (minimum, inv-norm transformed) | A | β: 0.019 | 1E-13 | PubMed |
| systolic blood pressure (SBP, maximum, inv-normal transformed) | A | β: 0.03 | 2E-12 | PubMed |
| Mean arterial pressure | A | OR: 0.32 | 2E-11 | PubMed |
| potassium (minimum, inv-norm transformed) | A | β: 0.016 | 3E-11 | PubMed |
| Diastolic blood pressure (MTAG) | G | β: 0.011 | 9E-11 | PubMed |
| Cardiovascular disease | — | — | 1E-10 | PubMed |
| Medication use (agents acting on the renin-angiotensin system) | G | β: 0.033 | 1E-10 | PubMed |
| Diastolic blood pressure | A | OR: 0.27 | 2E-10 | PubMed |
| Medication use (agents acting on the renin-angiotensin system) | G | β: 0.038 | 5E-10 | PubMed |
| Medication use (calcium channel blockers) | G | β: 0.05 | 8E-10 | PubMed |
| Systolic blood pressure | A | OR: 0.41 | 9E-10 | PubMed |
| Pulse pressure | G | OR: 0.15 | 1E-9 | PubMed |